ISDIN™ Corp. Launches New Non-Steroidal Treatment Approach For Facial Seborrheic Dermatitis

Introducing Nutraseb™ Facial Cream

News provided by

Aug 15, 2017, 10:18 ET

MORRISTOWN, N.J., Aug. 15, 2017 /PRNewswire/ -- Up to 5% of the population suffer from facial Seborrheic Dermatitis (SD), a chronic inflammatory skin disease affecting areas of the body that contain larger numbers of sebaceous glands and, ultimately, resulting in scaly, keratolytic (flakey), itchy, burning, and erythema (redness) of the skin.^{1, 2} The potential impact of seborrheic dermatitis is great on those who suffer from the diseases; it can affect individuals both physically and emotionally.

Introducing Nutraseb™ Facial Cream, a new topical prescription approach for multi-symptom management of facial Seborrhea and Seborrheic Dermatitis. Nutraseb™ Facial Cream is a steroid-free, fragrance free, water-based emulsion formulated to target all four aspects of SD: inflammation, fungus, sebum, and scaling.

"Nutraseb™ Facial Cream takes a 360-degree approach to manage seborrheic dermatitis by demonstrating anti-inflammatory, anti-fungal, sebum-reducing and scale-reducing properties," says Dr. Deanne Mraz Robinson. "It manages key components of Seborrheic Dermatitis and works to help relieve dry, waxy skin, by maintaining a moist wound and skin environment, which is beneficial to the healing process."

Nutraseb™ Facial Cream is backed by clinical data, showcasing the efficacy and tolerance of the product in the treatment of facial Seborrheic Dermatitis. Clinical results have been previously presented³:

Study 1: Evaluation of the efficacy of Nutraseb™ Facial Cream in the treatment of mild facial Seborrheic Dermatitis

Nutraseb™ Facial Cream proved to be successful in 87.5% of patients with mild dermatitis and 78.8% of patients considered the cream to be good or excellent.
Results of the study demonstrated the efficacy of Nutraseb™ Cream in 33 patients who were diagnosed with mild facial seborrheic dermatitis.
A significant number of patients had a decrease in erythema.

Study 2: Assessing the ability of Nutraseb™ Facial Cream and the cosmetic efficacy and cosmetic quality of the product

Results of the study demonstrated that after 20 people used the treatment for 21 days, more than 90% reported improvement of their symptoms, with the added bonus of skin moisturization.

"The ISDIN brand is an emerging skincare staple in the U.S. market leveraging our longstanding reputation in Spain and is pleased to be launching our very first prescription product in the U.S." says, Robert D'Urso, US Country Manager at ISDIN. "The introduction of Nutraseb™ Facial Cream to the marketplace demonstrates the company's vision to continually evolve and partner with Dermatologists to meet customer needs."

1. Del Rosso JQ. Adult seborrheic dermatitis: a status report on practical topical management. J Clin Aesthet Dermatol. 2011 May;4(5):32-8.
2. Goldenberg G. Optimizing treatment approaches in seborrheic dermatitis. J Clin Aesthet Dermatol. 2013 Feb;6(2):44-9.
3. Data on file. Morristown, NJ ISDIN Corp.: 2017

About Nutraseb™ Facial Cream
Nutraseb™ Facial Cream is contraindicated in persons with a known hypersensitivity to any of the components of the formulation. For topical use only. Avoid contact with eyes, not for ophthalmic use. The safety and effectiveness of Nutraseb™ has not been tested on subjects younger than age 22 years.

Keep out of the reach of children. Use only as directed. Nutraseb™ does not contain a sunscreen, use of sunscreen products and protective clothing over treated areas is recommended when exposure cannot be avoided. If condition does not improve within 10-14 days, consult a physician. For full prescribing information please visit www.nutraseb.com or see the supplied package insert.

About ISDIN Corp.^®Founded in 1975 and headquartered in Barcelona, Spain, ISDIN^® is a Spanish dermatology company with a 40-year history. It is jointly set up by the international business groups, Puig and Esteve, benchmarks both in the cosmetic, fashion and beauty, and pharmaceutical industries respectively. As a multinational company, ISDIN^® is committed to offering holistic skin care solutions with its portfolio of treatment and adjuvant therapy products to meet major dermatological needs and solve dermatological problems. Constant innovation and research share a common objective: development of products at the forefront of dermatology, advanced formulas and new textures. Having enjoyed rapid development since it was founded, ISDIN^® nowadays leads the skincare sector and is the #1 dermatological brand in Spain.

ISDIN^® is present mainly across Europe, Latin America, North America and South Africa with sales in over 30 countries. This includes Spain, France, Belgium, Portugal, Chile, Mexico, Brazil, Argentina, South Korea, and now, China and the US. ISDIN^® is trusted and recommended by dermatologists worldwide and has enjoyed great popularity among consumers all over the world for 40 years®.